Cargando…
Asiaticoside ameliorates renal ischemia/reperfusion injury by promoting CD4(+)CD25(+)FOXP3(+) treg cell differentiation
Ischemia/reperfusion injury (I/R) is the major cause of acute kidney injury, which becomes a global health problem. The effects of asiaticoside, as an anti-inflammatory drug, on renal ischemia-reperfusion injury have not been well defined. After the CD4(+) cells were treated with asiaticoside, the C...
Autores principales: | Tang, Shengjie, Xie, Xiangcheng, Wang, Ming, Wei, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395025/ https://www.ncbi.nlm.nih.gov/pubmed/37539103 http://dx.doi.org/10.1016/j.heliyon.2023.e17390 |
Ejemplares similares
-
Protective effects of asiaticoside on renal ischemia reperfusion injury in vivo and in vitro
por: Tang, Shengjie, et al.
Publicado: (2022) -
Protective Effect of CXCR3(+)CD4(+)CD25(+)Foxp3(+) Regulatory T Cells in Renal Ischemia-Reperfusion Injury
por: Jun, Cao, et al.
Publicado: (2015) -
Hepatitis B envelope antigen increases Tregs by converting CD4+CD25(-) T cells into CD4(+)CD25(+)Foxp3(+) Tregs
por: Tang, Rui, et al.
Publicado: (2020) -
Cells with Treg-specific FOXP3 demethylation but low CD25 are prevalent in autoimmunity
por: Ferreira, Ricardo C., et al.
Publicado: (2017) -
Adoptive Transfers of CD4(+)CD25(+) Tregs Raise Foxp3 Expression and Alleviate Mouse Enteritis
por: Wang, Kai, et al.
Publicado: (2018)